New research from the University of Chicago suggests that the mental health and social benefits often attributed to GLP-1 weight loss drugs like Ozempic and Wegovy may be more perception than reality. While many users report feeling happier or more confident, a study tracking thousands of patients over two years found little evidence of long-term improvements in employment, marital status, or clinical depression markers.
The Gap Between Patient Experience and Statistical Data
The study, which has not yet been peer-reviewed, analyzed data from the Medical Expenditure Panel Survey between 2012 and 2023. Researchers examined nearly 8,000 observations from adult diabetes patients to track changes in mental health, job status, and relationships. According to Robert Kaestner, an economist at the University of Chicago’s Harris School of Public Policy, the results showed that perceived gains in life satisfaction often failed to persist over time.
“We measured outcomes like whether someone became employed or unemployed, whether they got married or divorced, and standard indicators of mental health,” Kaestner stated. He noted that while these metrics are standard, they might overlook subtle, daily shifts in self-esteem or personal confidence that patients report.
A recent Gallup poll revealed that 15 percent of 5,065 adults surveyed have used weight loss drugs at some point, a significant increase from the 3 percent reported in 2024.
Conflicting Evidence on Social and Professional Gains
The University of Chicago findings stand in contrast to other recent observational papers. Some research has suggested that GLP-1 usage correlates with better dating and employment prospects, particularly for women who were already in the workforce. This discrepancy highlights the complexity of measuring “wellbeing” in clinical settings.
For many users, the primary driver for these claims is a boost in self-confidence. Alexus Murphy, a content creator on Zepbound, told CNN that the medication positively influenced her social life and personal presence. However, researchers emphasize that these subjective feelings of confidence are difficult to quantify in large-scale longitudinal studies compared to binary outcomes like employment status or divorce.
Health Benefits vs. Treatment Realities
While the social impact of weight loss drugs remains a subject of debate, the physical benefits are more clearly documented. Clinical data shows that these medications can improve heart and liver health and may lower the risk of cancer and dementia. Yet, these advantages come with significant trade-offs.
The drugs, which function by mimicking hormones that suppress appetite, are associated with high fail rates. Common side effects reported by patients include severe nausea and vomiting. In rare cases, users have reported more serious complications, including blindness, which complicates the long-term outlook for widespread adoption.
Frequently Asked Questions
- Do weight loss drugs improve long-term mental health?
Research from the University of Chicago found little evidence of long-term improvement in standard mental health markers among users over a two-year period. - Are there social benefits to taking Ozempic or Wegovy?
While some users report increased confidence, data on tangible social outcomes like marriage or employment remains inconsistent across different studies. - What are the primary risks of these medications?
Beyond physical health benefits, patients often face side effects such as extreme nausea, vomiting, and potential risks to vision.
Have you experienced changes in your daily life while taking weight loss medication? Share your thoughts in the comments below or subscribe to our newsletter for the latest updates on medical research.
Keep reading